MB

Moleculin Biotech

MBRX
NASDAQHealth Care

Income Statement

Total Revenue$0
Gross Profit$0
Operating Income$-26.64M
EBITDA$-18.07M
EBIT$-18.2M
Pre-tax Income$-30.33M
Net Income$-18.2M

Balance Sheet

Cash Equivalent$10.34M
Total Debt$404.5K
Book Value$14.49M
Book Value Per Share143.48

Key Ratios

Return on Equity (ROE)-363.99%
Return on Assets (ROA)-128.58%
Return on Invested Capital (ROI)-363.99%
Net Profit Marginundefined
Current Ratio0.97
Quick Ratio0.80
Long-Term Debt / Equitynull